250 mcg subcutaneous twice daily, near the injury, for 4 to 6 weeks
In some embodiments, the otic formulation or composition comprises about 4% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
In the ExA study, the METH intake after an acute treatment was 5.41 1.05 mg/kg in control and 4.72 0.71 mg/kg in LIR-treated rats (t-test, p = 0.625)
furthermore, lifetime coverage of GLP-1s can greatly inflate plan sponsor expenses and be unsustainable
RabotSMembrezMBruneauAGerardPHarachTMoserMet al
After TMB substrate solution is added, only those wells that contain Human IFNa, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color